AU4185100A - Compounds for therapy and diagnosis of lung cancer and methods for their use - Google Patents
Compounds for therapy and diagnosis of lung cancer and methods for their useInfo
- Publication number
- AU4185100A AU4185100A AU41851/00A AU4185100A AU4185100A AU 4185100 A AU4185100 A AU 4185100A AU 41851/00 A AU41851/00 A AU 41851/00A AU 4185100 A AU4185100 A AU 4185100A AU 4185100 A AU4185100 A AU 4185100A
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- therapy
- compounds
- methods
- lung cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/55—Lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28532399A | 1999-04-02 | 1999-04-02 | |
US09285323 | 1999-04-02 | ||
US09/370,838 US6444425B1 (en) | 1999-04-02 | 1999-08-09 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
US09370838 | 1999-08-09 | ||
US47623599A | 1999-12-30 | 1999-12-30 | |
US09476235 | 1999-12-30 | ||
US51880900A | 2000-03-03 | 2000-03-03 | |
US09518809 | 2000-03-03 | ||
PCT/US2000/008560 WO2000060077A2 (en) | 1999-04-02 | 2000-03-30 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4185100A true AU4185100A (en) | 2000-10-23 |
Family
ID=27501392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU41851/00A Abandoned AU4185100A (en) | 1999-04-02 | 2000-03-30 | Compounds for therapy and diagnosis of lung cancer and methods for their use |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1187915A2 (en) |
JP (1) | JP2002540790A (en) |
AU (1) | AU4185100A (en) |
HK (1) | HK1045332A1 (en) |
WO (1) | WO2000060077A2 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6759508B2 (en) | 2000-09-01 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
GB9924060D0 (en) * | 1999-10-11 | 1999-12-15 | Chiron Spa | VIP54 protein |
JP2004526401A (en) * | 2000-03-29 | 2004-09-02 | コリクサ コーポレイション | Compositions and methods for treatment and diagnosis of lung cancer |
TWI317379B (en) * | 2000-08-28 | 2009-11-21 | Teijin Ltd | Airway-specific trypsin-like enzymes and method of using the same |
CA2489623A1 (en) | 2001-06-21 | 2003-01-03 | Isis Innovation Limited | Atopy |
AU2007216892B2 (en) * | 2002-08-16 | 2011-02-10 | Agensys, Inc. | Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer |
EP1569514A4 (en) * | 2002-08-16 | 2007-10-31 | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines | |
WO2004016733A2 (en) * | 2002-08-16 | 2004-02-26 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
JP5648261B2 (en) * | 2006-12-20 | 2015-01-07 | 東レ株式会社 | Cancer detection method |
CN106039307A (en) | 2008-08-05 | 2016-10-26 | 东丽株式会社 | Pharmaceutical composition for treatment and prevention of cancer |
HUE027332T2 (en) * | 2008-08-05 | 2016-09-28 | Toray Industries | Cancer detection method |
WO2011096528A1 (en) * | 2010-02-04 | 2011-08-11 | 東レ株式会社 | Pharmaceutical composition for treatment and/or prevention of cancer |
KR101805520B1 (en) | 2010-02-04 | 2017-12-07 | 도레이 카부시키가이샤 | Pharmaceutical composition for treatment and/or prevention of cancer |
AU2011211700B2 (en) | 2010-02-04 | 2015-06-11 | Toray Industries, Inc. | Medicament for treating and/or preventing cancer |
PL2532680T3 (en) | 2010-02-04 | 2015-10-30 | Toray Industries | Medicinal composition for treating and/or preventing cancer |
RU2598258C2 (en) | 2010-02-04 | 2016-09-20 | Торэй Индастриз, Инк. | Pharmaceutical composition for treatment and/or prevention of cancer |
DK2532366T3 (en) * | 2010-02-04 | 2017-01-02 | Toray Industries | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR CANCER PREVENTION |
US9181348B2 (en) | 2011-08-04 | 2015-11-10 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
RU2610428C2 (en) | 2011-08-04 | 2017-02-10 | Торэй Индастриз, Инк. | Pharmaceutical composition for treating and/or preventing malignant growth |
PL2740489T3 (en) | 2011-08-04 | 2017-06-30 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of pancreatic cancer |
PL3351630T3 (en) | 2011-08-04 | 2020-05-18 | Toray Industries, Inc. | Pharmaceutical composition comprising anti caprin-1 antibodies for treating and/or preventing cancer |
KR101968498B1 (en) | 2011-08-04 | 2019-04-12 | 도레이 카부시키가이샤 | Drug composition for cancer treatment and/or prevention |
US9796775B2 (en) | 2011-08-04 | 2017-10-24 | Toray Industries, Inc. | Method for detecting pancreatic cancer |
JP6065592B2 (en) | 2011-08-04 | 2017-01-25 | 東レ株式会社 | Pharmaceutical composition for treatment and / or prevention of cancer |
AU2013223137B2 (en) | 2012-02-21 | 2017-10-19 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
WO2013125636A1 (en) | 2012-02-21 | 2013-08-29 | 東レ株式会社 | Pharmaceutical composition for treatment and/or prevention of cancer |
PT2824114T (en) | 2012-02-21 | 2019-08-05 | Toray Industries | Pharmaceutical composition for treatment of cancer |
IN2014KN01715A (en) | 2012-02-21 | 2015-10-23 | Toray Industries | |
HUE036425T2 (en) | 2012-03-30 | 2018-07-30 | Toray Industries | Pharmaceutical composition for treatment and/or prevention of gallbladder cancer |
MX358224B (en) | 2012-03-30 | 2018-08-10 | Toray Industries | Pharmaceutical composition for treatment and/or prevention of liver cancer. |
RU2646464C2 (en) | 2012-07-19 | 2018-03-05 | Торэй Индастриз, Инк. | Method for cancer detection |
EP2876446B1 (en) | 2012-07-19 | 2018-12-26 | Toray Industries, Inc. | Method for detecting cancer |
RU2678138C2 (en) | 2013-08-09 | 2019-01-23 | Торэй Индастриз, Инк. | Pharmaceutical composition for treatment and/or prevention of cancer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589579A (en) * | 1994-07-19 | 1996-12-31 | Cytoclonal Pharmaceutics, Inc. | Gene sequence and probe for a marker of non-small cell lung carinoma |
ID27813A (en) * | 1998-01-28 | 2001-04-26 | Corixa Corp | COMPOUNDS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER AND METHODS FOR USE |
-
2000
- 2000-03-30 JP JP2000609568A patent/JP2002540790A/en not_active Withdrawn
- 2000-03-30 AU AU41851/00A patent/AU4185100A/en not_active Abandoned
- 2000-03-30 WO PCT/US2000/008560 patent/WO2000060077A2/en not_active Application Discontinuation
- 2000-03-30 EP EP00921551A patent/EP1187915A2/en not_active Withdrawn
-
2002
- 2002-09-19 HK HK02106838.1A patent/HK1045332A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1187915A2 (en) | 2002-03-20 |
WO2000060077A3 (en) | 2002-01-17 |
HK1045332A1 (en) | 2002-11-22 |
JP2002540790A (en) | 2002-12-03 |
WO2000060077A2 (en) | 2000-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4185100A (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
HUP0200760A2 (en) | Compounds and methods for therapy and diagnosis of lung cancer | |
HUP0201757A3 (en) | Compositoins and methods for the therapy and diagnosis of lung cancer | |
ZA99693B (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use. | |
AU2001261007A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU1807401A (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
AU2002218770A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU7994200A (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2002311909A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU3391200A (en) | Compositions and methods for breast cancer therapy and diagnosis | |
AU2001252945A1 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
AU2002359330A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2001243349A1 (en) | Methods for the diagnosis and treatment of breast cancer | |
AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
AU5638400A (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU2002313726A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
AU2001273149A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |